Drug reference

beraprost

PGI2 analogue · Pulmonary Arterial Hypertension Agent

PGI2 analoguePulmonary Arterial Hypertension Agent

CDSCO approved

EXCRETION

—

not curated

INTERACTIONS

—

none in our sources

PREGNANCY

—

not curated

Mechanism

Beraprost is a PGI2 analogue, expected to exert similar relaxant and antiproliferative effects as other prostacyclins by activating the IPR and the cAMP-PKA pathway.

Related guidelines

Beta-blockers in hypertension

MOHFW · Cardiology · 2024

Hypertension in diabetes

MOHFW · Endocrinology · 2024

Hypertension in adults

OTHER · Cardiology · 2022

Hypertension in diabetes

RSSDI · Endocrinology · 2022

Extrapulmonary tuberculosis

ICMR · Infectious Diseases · 2022

Ask House about beraprost

Continue into a citation-backed clinical answer with the drug context already attached.

Open in workspace Ask House about this drug

Sources: Goodman & Gilman 14e·Verified: 2026-05-10 · House clinical team